HIMS Logo

Hims & Hers Health, Inc. (HIMS) 

NYSE
Market Cap
$5.5B
Sector
Consumer Defensive
Industry
Household & Personal Products
Rank in Sector
10 of 167
Rank in Industry
2 of 21

Largest Insider Buys in Sector

HIMS Stock Price History Chart

HIMS Stock Performance

About Hims & Hers Health, Inc.

Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, …

Insider Activity of Hims & Hers Health, Inc.

Over the last 12 months, insiders at Hims & Hers Health, Inc. have bought $2.08M and sold $150.05M worth of Hims & Hers Health, Inc. stock.

On average, over the past 5 years, insiders at Hims & Hers Health, Inc. have bought $2.25M and sold $69.24M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Payne Christopher D (director) — $3.9M. Manuel Anja (director) — $132,260.

The last purchase of 1,000 shares for transaction amount of $24,500 was made by Manuel Anja (director) on 2024‑11‑14.

List of Insider Buy and Sell Transactions, Hims & Hers Health, Inc.

2024-12-17SaleChief Commercial Officer
25,550
0.0124%
$32.20$822,710-15.81%
2024-12-17SaleChief Executive Officer
79,246
0.0383%
$32.09$2.54M-15.81%
2024-12-17SalePAO
10,012
0.0049%
$32.20$322,386-15.81%
2024-12-16SaleChief Executive Officer
125,661
0.0566%
$29.45$3.7M-8.29%
2024-12-16SalePAO
472
0.0002%
$29.58$13,962-8.29%
2024-12-10SaleChief Operating Officer
85,561
0.0411%
$31.01$2.65M-2.36%
2024-12-10SaleChief Commercial Officer
7,259
0.0036%
$32.25$234,103-2.36%
2024-12-02SaleChief Commercial Officer
2,054
0.001%
$33.56$68,932+1.09%
2024-12-02SaleChief Executive Officer
33,513
0.0169%
$33.38$1.12M+1.09%
2024-11-26SaleChief Legal Officer
2,343
0.0011%
$29.90$70,056+1.43%
2024-11-25SaleChief Commercial Officer
17,303
0.007%
$26.49$458,356-1.13%
2024-11-25SaleChief Financial Officer
101,993
0.046%
$29.62$3.02M-1.13%
2024-11-19SaleChief Commercial Officer
7,500
0.0032%
$22.00$165,000-0.46%
2024-11-18SaleChief Operating Officer
58,750
0.027%
$21.04$1.24M+4.06%
2024-11-18SalePAO
472
0.0002%
$19.42$9,166+12.77%
2024-11-14Purchasedirector
1,000
0.0006%
$24.50$24,500-21.14%
2024-11-13Saledirector
40,000
0.0205%
$29.99$1.2M+11.78%
2024-11-13SaleChief Financial Officer
142,886
0.073%
$29.93$4.28M+11.78%
2024-11-12SaleChief Legal Officer
2,338
0.0011%
$26.46$61,863+15.27%
2024-11-12Purchasedirector
4,000
0.0019%
$26.94$107,760+15.27%

Insider Historical Profitability

12.16%
WELLS DAVID Bdirector
156036
0.0743%
$26.2044<0.0001%
Payne Christopher Ddirector
110000
0.0524%
$26.2010
Okupe OluyemiChief Financial Officer
109392
0.0521%
$26.20120+79.72%
Dudum AndrewChief Executive Officer
30710
0.0146%
$26.20238<0.0001%
Manuel Anjadirector
5000
0.0024%
$26.2020

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$221.38M6.6614.31M+0.97%+$2.12M<0.01
BlackRock$168.01M5.0610.86M+<0.01%+$17,156.23<0.01
Marshall Wace$87.25M2.635.64M+7.04%+$5.74M0.09
Institutional Venture Management Xv Llc$80.79M2.435.22M-32.37%-$38.67M41.61
Institutional Venture Management Xvi Llc$80.79M2.435.22M-32.37%-$38.68M93.86
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.